Elanco Animal Health Incorporated Common Stock

Elanco Animal Health Incorporated Common Stock

Compare this stock

ELAN Stock Report Card

$

VolatilityTechnicalsProfitPerformanceEarningsAnalyst Price Targets

56%

Performance

Score:

10/100

ELAN returned -9.80% in the last 12 months. Based on SPY's performance of 13.09%, its performance is below average giving it a score of 10 of 100.

Analyst Price Targets

Score:

64/100

11 analysts offer 12-month price targets for ELAN. Together, they have an average target of 27, the most optimistic target put ELAN at 37 within 12-months and the most pessimistic has ELAN at 18.

Technicals

Score:

89/100

ELAN receives a 89 of 100 based on 14 indicators. 12 are bullish, 1 are bearish.

Earnings

Score:

100/100

ELAN has missed earnings 1 times in the last 20 quarters.

Profit

Score:

22/100

Out of the last 20 quarters, ELAN has had 6 profitable quarters and has increased their profits year over year on 2 of them.

Volatility

Score:

45/100

ELAN has had a lower than average amount of volatility over the last 12 months giving it a score of 44 of 100.

Elanco Animal Health Incorporated Common Stock Summary

New York Stock Exchange / ELAN
Healthcare
Drug Manufacturers - Specialty & Generic
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.